Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.
PrivateLast Round
Strategic
Oct 16, 2025
Total Funding Raised
$37.08M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. is a biotechnology company that specializes in the research, development, and industrialization of cell and gene therapies, including CAR-T and CAR-NK drugs for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Comparables
Compare Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chongqing Precision Biotech Co., Ltd. | 90% | |
| Juventas Cell Therapy Ltd. | 88% | |
| Shanghai YaKe Biotechnology Co., Ltd. | 87% | |
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 16, 2025 | ||||
| VC Round | Jun 7, 2021 | ||||
| VC Round | Jun 3, 2021 | ||||
| Series B | Nov 16, 2020 | ||||
| Series A | Apr 1, 2018 | ||||
Pre Seed | May 1, 2017 |
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guoke Jiahe Capital | Series B, Series A |
| Shenzhen Guozhong Venture Capital Management | Series A |
| Hunan High-tech Venture Capital Group Co., Ltd. | Series B |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
$120M raised, led by Kite Pharma.
- Jun 7, 2021
Completed a VC Round funding round.
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.